Fujirebio Diagnostics Inc - Company & Market Research Reports

Home /
Companies /
Fujirebio Diagnostics Inc

Fujirebio Diagnostics manufactures and supplies in vitro diagnostics and biomarkers. Fujirebio Diagnostics specializes in the manufacturing of manual assay products, reagents and controls distributed throughout the U.S. and around the world, as well as custom-developed products for use through our worldwide network of distribution partners. The company was founded in 1979 and is based in Malvern, Pennsylvania with manufacturing facilities in Malvern, Pennsylvania; Seguin, Texas; and Goteborg, Sweden.

REFINE BY

KEYWORD

Immunoassay Market - Forecasts from 2025 to 2030

 Report
December 2024
135 Pages
Global

From

€2791EUR$3,160USD£2,414GBP

€3489EUR$3,950USD£3,017GBP

Prostate Cancer Diagnostics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,430GBP

2024 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

 Report
August 2024
430 Pages
United States

From

€2429EUR$2,750USD£2,101GBP

2024 UK Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

 Report
August 2024
408 Pages
United Kingdom

From

€2429EUR$2,750USD£2,101GBP

2024 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

 Report
August 2024
407 Pages
Spain

From

€2429EUR$2,750USD£2,101GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

2024 Italy Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

 Report
August 2024
402 Pages
Italy

From

€2429EUR$2,750USD£2,101GBP

2024 Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

 Report
August 2024
407 Pages
Germany

From

€2429EUR$2,750USD£2,101GBP

2024 France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

 Report
August 2024
407 Pages
France

From

€2429EUR$2,750USD£2,101GBP

2024 Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: France, Germany, Italy, Spain, UK - Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

 Report
August 2024
495 Pages
Europe, United Kingdom, ... Europe, United Kingdom, Spain, Italy, Germany, France

From

€4283EUR$4,850USD£3,705GBP

2024 Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

 Report
August 2024
410 Pages
Japan

From

€2429EUR$2,750USD£2,101GBP

2024 Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: US, Europe, Japan - Supplier Shares and Segment Forecasts by Country, Emerging Technologies, Competitive Strategies

 Report
August 2024
570 Pages
Japan, United States, ... Japan, United States, Europe, Global

From

€5741EUR$6,500USD£4,965GBP

Lateral Flow Assays Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,430GBP

2025 Blood Banking Market Shares in the US, Europe, and Japan-Competitive Analysis of Leading and Emerging Market Players

 Report
June 2025
Europe, United States Europe, United States

From

€1634EUR$1,850USD£1,413GBP

Virology Testing Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,430GBP

Immunodiagnostics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,430GBP

2024 Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics Market - Growth Opportunities in France, Germany, Italy, Spain, UK

 Report
June 2024
Europe, United Kingdom, ... Europe, United Kingdom, Spain, Italy, Germany, France

From

€7507EUR$8,500USD£6,493GBP

2024 Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics Market - Growth Opportunities in the US, Europe, Japan

 Report
June 2024
Global, Europe, United States, ... Global, Europe, United States, Japan

From

€12806EUR$14,500USD£11,077GBP

2024 North America Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics Market - Growth Opportunities in the US, Canada, Mexico

 Report
June 2024
North America, Mexico, ... North America, Mexico, Canada

From

€5741EUR$6,500USD£4,965GBP

2024 Middle Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics Market - Growth Opportunities in 11 Countries

 Report
June 2024
Global

From

€6624EUR$7,500USD£5,729GBP

2024 Czech Republic Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks

 Report
June 2024
Czech Republic

From

€1634EUR$1,850USD£1,413GBP

1,557 Results (Page 39 of 78)
- 1
- 37
- 38
- 39
- 40
- 41

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.